Advertisement

Neue Kontrastmittel

  • Friedrich Cavagna
Chapter

Zusammenfassung

Die Magnetresonanztomographie (MRT) bietet die Möglichkeit zur Verkürzung des Ablaufs bei der Diagnostik der koronaren Herzerkrankung, indem Funktion, Perfusion und Vitalität des Herzmuskels sowie die Anatomie der Herzkranzgefäße in einer einzigen Untersuchung abgebildet und bestimmt werden. Dabei kann die Anwendung von Kontrastmitteln, insbesondere neuer intravasaler Kontrastmittel (IKM), eine entscheidende Rolle spielen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Cavagna FM, Anelli PL, Lorusso V et a (2001) B-22956, A New Intravascular Contrast Agent for MR Coronary Angiography. Proc Intl Soc Mag Reson Med 9:519Google Scholar
  2. 2.
    Corot C, Port M, Raynal I, Dencausse A et al (2000) Physical, chemical and biological evaluations of P760: A new gadolinium complex characterized by a low rate of interstitial diffusion. J Magn Res Imaging 11:182–191CrossRefGoogle Scholar
  3. 3.
    De Haen C, Anelli PL, Lorusso V et al (2001) A New Intravascular Contrast Agent for MR Coronary Angiography; B-22956. Investigative Radiology, in pressGoogle Scholar
  4. 4.
    Hofman MBM, Bedaux WLF, Wielopolski PA et al (2000) Improvement of MR Coronary Angiography in Patients using the New Blood Pool Contrast Agent Clariscan. Proc Intl Soc Mag Reson Med 8:265Google Scholar
  5. 5.
    Ogan MD, Schmiedl U, Moseley E et al (1987) Invest Radiol 22:665–671PubMedCrossRefGoogle Scholar
  6. 6.
    Parmalee DJ, Walovitch RC, Quellet AS et al (1997) Preclinical evaluation of the pharmakokinetics, biodistribution and elimination of MS-325, a blood pool agent for Magnetic Resonance Imaging. Invest Radiol 32:741–747CrossRefGoogle Scholar
  7. 7.
    Pruessman KP, Weiger M, Scheidegger MB, Bösiger P (1999) SENSE: Sensitivity Encoding for Fast MRI. Magn Reson Med 42:952–962CrossRefGoogle Scholar
  8. 8.
    Taylor AM, Panting JR, Keegan J et al (1999) Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. JMRI 9:220–227PubMedCrossRefGoogle Scholar
  9. 9.
    Wagenseil JE, Johansson LO, Lorenz CH (1999) Characterization of T1 Relaxation and Blood-Myocardial Contrast Enhancement of NC100150 Injection in Cardiac MRI. JMRI 10:784–789PubMedCrossRefGoogle Scholar
  10. 10.
    Wendland MF, Saaed M, Lund G et al (1999) Contrast Enhanced MRI for Quantification of Myocardial Viability. JMRI 10:694–702PubMedCrossRefGoogle Scholar
  11. 11.
    Wilke NM, Jerosch-Herold M, Wang Y et al (1997) Myocardial Perfusion Reserve Assessment with Multislice, Quantitative, First Pass MR Imaging. Radiology 204:373–384PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Friedrich Cavagna

There are no affiliations available

Personalised recommendations